When I was taking 8-10mg per week, my A1C mysteriously went higher to 5.5 (there could be another reason but that’s my educated guess). I took a little break and dropped it to 5mg per week and now my A1C is down to 4.9.
I think dosage is a key factor here and I was probably using too much.
OK, but NZ has a lot more vibrant greenery. Nothing in Australia is as green as some fields in NZ. NZ is almost on par with Ireland for the intensity of the green. Australia is a parched red hostile land (except the fabulous beaches ), by contrast NZ looks like a land of milk and honey. Of course appearances can be deceiving, but nobody can deny that NZ is spectacularly beautiful.
Indeed. I was fortunate enough to visit NZ and it was the most gorgeous place I’ve ever seen. Still many places I haven’t been, though.
Out of curiosity, during my vacation I asked about moving there and was told you needed to be under a certain age and have a certain net worth so you wouldn’t be a drain on their system. In a quick AI search, it seems that was not exactly true. If seems if you are past the age of 55, you can buy your way in through large investments.
The results aren’t public yet, but Brad said on his discord server that if he were to take Rapamycin, it would be every six weeks or every three months. He hasn’t stated why, but I imagine he will once the results are available.
@John_Hemming takes it this way, but Brad didn’t mention anything about dosing.
Accepted 25 days ago and still no PDF online. Publication processes are so archaic, lol. Solid journal though, and Wiley is very legit. I have high hopes for the final paper.
Rapamycin does a clean up of bad mitochondria. If you are in your 30s it is worth trying to keep your body functioning as if you are in your 30s rather than wait until you are in your 60s.
FWIW, in animal models earlier initiation of rapamycin gives a bigger life extension. It’s true that rapamycin is effective when initiated at an older age, but that doesn’t mean an organism doesn’t do even better when started earlier.
Dr. Brad Stanfield’s trial, however well meaning, is mostly worthless based on the number of participants and length of trial.
I place more value on the discussions and feed back of forum members. The trial mainly proves he didn’t croak anybody with the dose and length of time administered.
Agreed. I don’t know the result, but I’d be surprised if the group taking Rapamycin was worse off in terms of muscle gain. I would assume the most likely result is no significant difference between the groups. But we shall see, soon, hopefully!
I think Brad has already hinted at the results… a small positive benefit, but the N is too small to be really definitive… so needs another larger trial to confirm.
These types of results don’t change anything for us. I think he’s now going for his PHD with this as the topic he’s focusing on for it.
But he will have access to studies and medical information we do not have yet. Putting a focus on Rapamycin could have the effect of attracting interest from other individuals who had not yet considered its importance. Stay tuned!!! This is exciting!!